These ranges are educational only and should not be used as a self-directed protocol
doi:10.1016/j.androl.2019.09.001
Primary Cellular Pathways FAK/Paxillin Signaling Cell Migration Enhancement BPC-157 significantly increases phosphorylation of focal adhesion kinase (FAK) and paxillin proteins in fibroblast cells, promoting enhanced cell adhesion and migration
Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes
Symptoms include loss of appetite, tingling in hands and feet, poor memory and depression
While the full effects of BPC-157 can take several weeks to be fully realized, the initial improvement in discomfort and swelling is often evident within the first few days of administration